Celltrion pushes for broader use of its COVID-19 treatment
Celltrion is trying to push for a more expansive use for Regkirona, its COVID-19 treatment, globally. The inhalable Regkirona has ...
Celltrion is trying to push for a more expansive use for Regkirona, its COVID-19 treatment, globally. The inhalable Regkirona has ...
Celltrion Healthcare announced on Wednesday that it would commence clinical trials of Remsima, an anti-inflammatory biosimilar, on COVID-19 patients this month ...
Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |